Volume 1, Issue 1 - 2026
Mechanisms by Which Lipid-Lowering Agents Modulate the Lipid-Inflammation Circuit and Their Stratified Clinical Use in Rheumatic Immune-Mediated Diseases
Lei Wang, Yao Wang, Baofeng Zhu, Mingjun Wang, Feng Li
2026, 1(1): 7. doi: 10.53941/bab.2026.100007
From Ex Vivo to In Vivo: The Next Generation of CAR-T Therapy
Yuhan Jiang, Ke-Fei Xu
2026, 1(1): 6. doi: 10.53941/bab.2026.100006
Enhancing Biological Field Effect Transistors (Bio-FETs) Performance for Alzheimer’s Disease Diagnostics: Microfluidics and Artificial Intelligence Integration
Jiao Wang, Zi-Jin Wei, Zi-An Zhao, Yan-Hong Liu, Ke-Yu Yao, James Chung-Wai Cheung
2026, 1(1): 5. doi: 10.53941/bab.2026.100005
Kanamycin Aptamer SELEX Coming to a Full Loop
Yijing Chen, Juewen Liu
2026, 1(1): 4. doi: 10.53941/bab.2026.10004
Functional MOF-Mediated Platforms for Potentiating Tumor Hyperthermia: A Review
Diyi Feng, Liqin Ge
2026, 1(1): 3. doi: 10.53941/bab.2026.100003
Transient Dietary Stress and Tumor Immunity: From High-Fat Diet-Induced Ferroptotic Memory to Broader Immunometabolic Regulation
Qi Gong, Pengcheng Hu
2026, 1(1): 2. doi: 10.53941/bab.2026.100002
Have Large Language Models Improved Research Methodology?
Fredric Narcross, Robert Marks
2026, 1(1): 1. doi: 10.53941/bab.2026.100001
